Drugs like ketamine can relieve depression symptoms, including suicidal thoughts, within hours, but they also carry risks that patients need to understand.
Rigor académico, oficio periodístico
Artículos sobre Drugs
Mostrando 121 - 140 de 455 artículos
Out of the 400 plus chemical compounds in the cannabis plant, CBD and THC are only the most well-known, and researched, cannabinoids.
Addiction remains shrouded in stigma, while the system through which we provide addiction treatment in Australia is fragmented and failing. There’s no better time to address these issues.
Possessing heroin, cocaine, meth and other drugs for personal use is no longer a criminal offense in Oregon. The idea is to get people with problem drug use help, not punishment.
It’s limiting to think about about sexual enhancement in purely negative, physical terms.
Gen Z is breaking stereotypes, but there are still some worrying trends when it comes to substance abuse.
People with alcohol or substance dependency already struggle to access mental health treatment, covid will only make this worse.
It’s hard to get an accurate picture of how the pandemic has influenced drug use, but initial data suggests treatment services are reporting increased demand.
Social media makes it easy to spread ‘fake news’.
Can’t make up your mind in the recreational cannabis referendum? You’re not alone, so here’s some tips from both sides of the debate to help you decide.
The voices of recreational cannabis users are curiously missing from the official debate about legalisation.
There are ingredients in your pills other than the one designed to treat your ailments. Those unnamed ingredients can alter how you respond to a medicine or even make you sick.
While many people said they drank more during the pandemic, others actually drank less, mainly because socialising at clubs, pubs and parties wasn’t possible.
Bolivia’s drug control strategy was once internationally applauded.
The head lice drug ivermectin is being touted as a coronavirus killer. But studies suggest it would need to be taken in mega-doses far higher than those currently used, with unknown side-effects.
With all the attention focussed on combating the spread of COVID-19 it’s easy to forget the other health challenges that could affect us all.
Conventional thinking on drugs, conflict and development isn’t working – here’s why.
Illicit and legitimate trade are closely connected, so how come one seems to be rising while the other has plunged?
With regular music festivals, people can more easily seek help or advice about drug and alcohol or mental health issues. But with drive-ins we need to be creative to minimise harms.
When news reports tout a drug, people get interested, even if the benefits are unproven. Patient hopes, requests and demands can easily turn into real prescriptions in their doctor’s office.
Principales colaboradores
-
Honorary Fellow, Department of Health Sciences, University of York
-
Adjunct Professor at the National Drug Research Institute (Melbourne based), Curtin University
-
Senior Lecturer of Addiction, Edith Cowan University
-
Professor in Substance Use, Liverpool John Moores University
-
Joel Lexchin es Amigo de The Conversation.
Professor Emeritus of Health Policy and Management, York University, Canada
-
Vice Chancellor’s Senior Research Fellow, Social Equity Research Centre and Digital Ethnography Research Centre, RMIT University
-
Associate Professor of the School of Pharmacy, University of Sydney
-
Professor in Criminal Justice and Faculty Director of Public Engagement, University of Kent
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
University of Sydney
-
Lecturer, RMIT University
-
Senior Lecturer in Chemistry, University of Birmingham
-
PhD Candidate, Royal Holloway University of London
-
Senior Lecturer in Criminology, Deakin University
-
Professor & Specialist in Drug Policy, UNSW Sydney
